Smart Meter Recognized by The Journal of mHealth as a Global Digital Health 100 Company
Awards Program Highlights Technology Companies on a Global Scale That are Demonstrating the Greatest Potential to Change the Way Healthcare is Delivered
TAMPA, Fla- January 31, 2019- Smart Meter, an innovative diabetes management data, technology and solutions company, announced today that The Journal of mHealth has recognized the company for the annual Global Digital Health 100, an acclaimed and diverse list distinguishing the most innovative companies working in the Health-Tech industry. Smart Meter was selected for its innovative iGlucose Cellular Diabetes Care Solution which provides a global level of simplified connectivity for a person with diabetes, allowing their healthcare professional to have more consistent and complete access to their data in order to provide better informed care between and during office visits.
As a trusted resource for those interested in advanced health technologies, technology-enabled healthcare, medical devices, and digital health services, The Journal of mHealth is widely read by audiences from around the world. The Global Digital Health 100 was designed by the publication to provide insight into key and emerging trends from across the healthcare continuum in regards to adoption of technology-led products and services. The program has now become one of the industry’s foremost technology award programs, celebrating innovation, entrepreneurship and health technology companies that are demonstrating the greatest potential to change the way that healthcare is delivered.
Matthew Driver, managing editor of The Journal of mHealth, explains what distinguishes this year’s list from years past, “In past years, many of our featured technologies have been limited by their relatively small user groups, but as the healthcare technology market continues to mature, we are now beginning to see more and more solutions that are successfully delivering these technology-driven modalities to much larger user bases.”
A six-month judging period and analysis took place in order to determine the list of honorees. The Journal’s editorial and advisory team reviewed nominations from startups to established corporations across the Health-Tech ecosystems and utilized a criterion of 10 different quantitative and qualitative evaluation metrics. This included disruptive impact, proof of concept, technology innovation, social value, effectiveness, execution of strategy, and, industry integration. All 100 companies selected demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale.
“Smart Meter is honored to be named among the esteemed list of Global Digital Health 100 companies for our achievements and innovation with the iGlucose Diabetes Care Solution,” said Cliff McIntosh, CEO of Smart Meter. “Over the past year, iGlucose experienced increasing market traction as a result of our global cellular connectivity. Through clinical studies, customer pilots and strategic partnerships, it has also been proven that real-time results data can transform diabetes management for both the person with diabetes and allow for better remote monitoring by their healthcare provider. With CMS now creating CPT codes making remote monitoring reimbursable, iGlucose is being recognized as a perfect fit.”
About The Journal of mHealth
The Journal of mHealth is the "Voice of the HealthTech Industry". A trusted resource for anyone with an interest in innovative health technologies, technology-enabled healthcare, medical devices, and digital health services, the Journal is widely read by audiences from around the world.
It is a leading international publication bringing the latest developments in innovative emerging health technologies to healthcare and industry professionals around the world. Featuring, the Latest Industry News, Articles, Research, Industry Whitepapers and Market Reports.
Anyone wishing to read the current edition of the Journal, or to subscribe, can do so by visiting www.thejournalofmhealth.com.
About Smart Meter, LLC
Smart Meter is an innovative diabetes management data, technology and solutions company that supports and enables connected health through the proactive management of diabetes. Its iGlucose Cellular Diabetes Care Solution provides a global level of simplified connectivity for the person with diabetes, the health care professional, payer and strategic partner. The iGlucose Solution starts with the iGlucose Cellular System, a simple, convenient and affordable way for people to test their blood and seamlessly record and share those results. The iGlucose Population Management Portal, is a powerful tool to review real-time data for clinicians and others managing populations for improved remote monitoring. An iGlucose API makes it easy to integrate the iGlucose data into any existing patient management or support platform. To learn more, visit www.iglucose.com or watch this short overview video. You can also follow us on Twitter at @iglucose, or LinkedIn at Smart Meter LLC.
